100 related articles for article (PubMed ID: 7838146)
21. Interaction of wild type and dominant-negative p55PIK regulatory subunit of phosphatidylinositol 3-kinase with insulin-like growth factor-1 signaling proteins.
Mothe I; Delahaye L; Filloux C; Pons S; White MF; Van Obberghen E
Mol Endocrinol; 1997 Dec; 11(13):1911-23. PubMed ID: 9415396
[TBL] [Abstract][Full Text] [Related]
22. Identification by mutation of the tyrosine residues in the insulin receptor substrate-1 affecting association with the tyrosine phosphatase 2C and phosphatidylinositol 3-kinase.
Rocchi S; Tartare-Deckert S; Mothe I; Van Obberghen E
Endocrinology; 1995 Dec; 136(12):5291-7. PubMed ID: 7588273
[TBL] [Abstract][Full Text] [Related]
23. Characterization of insulin and insulin-like growth factor-I actions in the bovine luteal cell: regulation of receptor tyrosine kinase activity, phosphatidylinositol-3-kinase, and deoxyribonucleic acid synthesis.
Chakravorty A; Joslyn MI; Davis JS
Endocrinology; 1993 Sep; 133(3):1331-40. PubMed ID: 8396016
[TBL] [Abstract][Full Text] [Related]
24. Insulin and IGF-I signaling through the insulin receptor substrate 1.
Keller SR; Lamphere L; Lavan BE; Kuhné MR; Lienhard GE
Mol Reprod Dev; 1993 Aug; 35(4):346-51; discussion 351-2. PubMed ID: 8398112
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol-3 kinase in human thymocytes.
Kooijman R; Lauf JJ; Kappers AC; Rijkers GT
J Exp Med; 1995 Aug; 182(2):593-7. PubMed ID: 7543144
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
Chan TW; Pollak M; Huynh H
Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
[TBL] [Abstract][Full Text] [Related]
27. Insulin like growth factor-I induces limited association of phosphatidylinositol 3-kinase to its receptor.
Yamamoto K; Lapetina EG; Moxham CP
Endocrinology; 1992 Mar; 130(3):1490-8. PubMed ID: 1311242
[TBL] [Abstract][Full Text] [Related]
28. SH2 domains of the p85 alpha subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors.
McGlade CJ; Ellis C; Reedijk M; Anderson D; Mbamalu G; Reith AD; Panayotou G; End P; Bernstein A; Kazlauskas A
Mol Cell Biol; 1992 Mar; 12(3):991-7. PubMed ID: 1372092
[TBL] [Abstract][Full Text] [Related]
29. The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidylinositol 3-kinase to phosphorylated platelet-derived growth factor beta receptor.
Klippel A; Escobedo JA; Fantl WJ; Williams LT
Mol Cell Biol; 1992 Apr; 12(4):1451-9. PubMed ID: 1312663
[TBL] [Abstract][Full Text] [Related]
30. Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action.
Kato H; Faria TN; Stannard B; Roberts CT; LeRoith D
Mol Endocrinol; 1994 Jan; 8(1):40-50. PubMed ID: 7512194
[TBL] [Abstract][Full Text] [Related]
31. Role of p85 subunit of phosphatidylinositol-3-kinase as an adaptor molecule linking the insulin receptor, p62, and GTPase-activating protein.
Sung CK; Sánchez-Margalet V; Goldfine ID
J Biol Chem; 1994 Apr; 269(17):12503-7. PubMed ID: 8175658
[TBL] [Abstract][Full Text] [Related]
32. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
Valverde AM; Lorenzo M; Pons S; White MF; Benito M
Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
[TBL] [Abstract][Full Text] [Related]
33. In vivo binding properties of SH2 domains from GTPase-activating protein and phosphatidylinositol 3-kinase.
Cooper JA; Kashishian A
Mol Cell Biol; 1993 Mar; 13(3):1737-45. PubMed ID: 8382774
[TBL] [Abstract][Full Text] [Related]
34. Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase.
Zahradka P; Litchie B; Storie B; Helwer G
Endocrinology; 2004 Jun; 145(6):2978-87. PubMed ID: 14976148
[TBL] [Abstract][Full Text] [Related]
35. Prolonged vs transient roles for early cell cycle signaling components.
Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
[TBL] [Abstract][Full Text] [Related]
36. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
[TBL] [Abstract][Full Text] [Related]
37. Interferon-alpha engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3'-kinase.
Uddin S; Yenush L; Sun XJ; Sweet ME; White MF; Platanias LC
J Biol Chem; 1995 Jul; 270(27):15938-41. PubMed ID: 7608146
[TBL] [Abstract][Full Text] [Related]
38. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
[TBL] [Abstract][Full Text] [Related]
39. Interaction of the insulin receptor beta-subunit with phosphatidylinositol 3-kinase in bovine ROS.
Rajala RV; Anderson RE
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3110-7. PubMed ID: 11726610
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the P85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity.
Damen JE; Cutler RL; Jiao H; Yi T; Krystal G
J Biol Chem; 1995 Oct; 270(40):23402-8. PubMed ID: 7559499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
